National Health Investors/$NHI
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About National Health Investors
National Health Investors Inc is a self-managed REIT that owns, leases, operates, and finances the development of senior housing communities and medical facilities. It operates through two segments: Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates the majority of revenue, includes real estate leases, mortgages, and other notes receivable related to independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment consists of ventures that own and operate independent living facilities. The company's revenues are derived from rental income, interest and other income, and resident fees and services.
- Ticker
- $NHI
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 32
- Headquarters
- Murfreesboro, United States
- Website
- www.nhireit.com
NHI Metrics
BasicAdvanced
$3.3B
19.35
$3.46
0.56
$2.76
5.49%
Price and volume
Market cap
$3.3B
Beta
0.56
52-week high
$91.38
52-week low
$63.51
Average daily volume
315K
Dividend rate
$2.76
Financial strength
Current ratio
1.817
Quick ratio
1.195
Long term debt to equity
0.804
Total debt to equity
0.804
Dividend payout ratio (TTM)
105.26%
Interest coverage (TTM)
3.37%
Profitability
EBITDA (TTM)
289.674
Gross margin (TTM)
73.93%
Net profit margin (TTM)
38.28%
Operating margin (TTM)
45.57%
Effective tax rate (TTM)
0.44%
Revenue per employee (TTM)
$13,620,000
Management effectiveness
Return on assets (TTM)
4.39%
Return on equity (TTM)
10.72%
Valuation
Price to earnings (TTM)
19.351
Price to revenue (TTM)
7.378
Price to book
2.1
Price to tangible book (TTM)
2.1
Price to free cash flow (TTM)
12.93
Free cash flow yield (TTM)
7.73%
Free cash flow per share (TTM)
5.185
Dividend yield (TTM)
4.12%
Forward dividend yield
5.49%
Growth
Revenue change (TTM)
24.99%
Earnings per share change (TTM)
10.42%
3-year revenue growth (CAGR)
12.36%
10-year revenue growth (CAGR)
6.35%
3-year earnings per share growth (CAGR)
11.05%
10-year earnings per share growth (CAGR)
-2.22%
3-year dividend per share growth (CAGR)
0.74%
10-year dividend per share growth (CAGR)
0.50%
What the Analysts think about NHI
Analyst ratings (Buy, Hold, Sell) for National Health Investors stock.
Analyst projections of the future price of National Health Investors stock.
Bulls say / Bears say
The NHC portfolio sale cut exposure to skilled nursing and a major tenant, while proceeds lowered leverage and gave NHI more room to invest. Fitch revised its outlook to positive, citing the lower reimbursement risk and a stronger, more private-pay portfolio. (Fitch Ratings, National Health Investors)
NHI is still finding senior-housing deals at attractive initial yields: its October purchase of six properties is expected to yield about 7.0% before routine capital costs. It also reported $164.3 million of signed investment opportunities in October, giving it scope to replace income from assets it has sold. (National Health Investors)
The SHOP business is scaling, with total second-quarter NOI up 188% year on year as acquisitions expanded the portfolio. There were also signs of improving operations: NOI at recently added properties rose about 7.6% from the first quarter, and same-store NOI increased 18.9% sequentially. (National Health Investors, Investing.com)
Legacy SHOP operations are struggling to fill rooms: same-store occupancy fell to 85.1% in the second quarter, down four percentage points from the end of 2025. Same-store NOI was also down 6.3% year on year, making the expected recovery a key execution risk. (Senior Housing News)
Bickford, which leases 37 properties, remains a credit concern: NHI says it continues to account for the tenant on a cash basis because substantial doubt about Bickford’s ability to continue as a going concern has not been alleviated. Any deterioration could put rent collections at risk. (SEC)
Selling the NHC properties removes recurring rent that must be replaced, while the large sale gain flatters reported earnings rather than providing ongoing rental income. NHI’s 2026 guidance includes an estimated $565.9 million to $566.3 million gain on dispositions, so headline net income is a poor guide to recurring performance. (National Health Investors, SEC)
Data summarised monthly by Lightyear AI. Last updated on 29 Oct 2026.
NHI Financial Performance
Revenues and expenses
NHI Earnings Performance
Company profitability
Upcoming events
NHI News
AllArticlesVideos
Funds containing NHI
AllUSDEURGBP
Fund name | Fund size | $NHI weighting |
|---|---|---|
iShares Developed Markets Property Yield£IWDP | $1.2B | 0.19% |
iShares Developed Markets Property Yield$IDWP | $1.2B | 0.19% |
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.18% |
iShares S&P Small Cap 600£ISP6 | $3.2B | 0.18% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.11% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.